Search Login Register
lipoarabinomannan
(LAM)
Summary
Description:
phosphorylated lipopolysaccharide antigen common to Mycobacterium leprae & Mycobacterium tuberculosis
Also Known As:
LAM; LAM-B; lipoarabinomannan-B
Networked: 1374
relevant articles (107 outcomes,
169 trials/studies)
for this Bio-Agent
Key Diseases for which lipoarabinomannan is
Relevant
-
Chronic Hepatitis B
:
34 outcomes 32 studies in 137 results
-
Infection
:
19 outcomes 13 studies in 120 results
-
Hepatitis B
:
16 outcomes 20 studies in 67 results
-
Amenorrhea
:
8 outcomes 12 studies in 44 results
-
Fibrosis (Cirrhosis)
:
5 outcomes 4 studies in 24 results
Show All >>
Drugs Related to lipoarabinomannan
-
Lamivudine (3TC)
-
adefovir dipivoxil (Hepsera)
-
adefovir
-
entecavir
-
Hepatitis B e Antigens
-
hepatitis B hyperimmune globulin
-
Immunoglobulins (Immunoglobulin)
-
DNA (Deoxyribonucleic Acid)
-
Sirolimus (Rapamycin)
-
telbivudine
Show All >>
Therapies Related to lipoarabinomannan
-
Liver Transplantation
-
Transplantation (Transplant Recipients)
-
Contraception (Birth Control)
-
Aftercare (After-Treatment)
-
Natural Family Planning Methods (Natural Family Planning)
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.